BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharmaceuticals Market Cap

BioCryst Pharmaceuticals has a market cap or net worth of $2.07 billion as of June 23, 2025. Its market cap has increased by 49.08% in one year.

• Market Cap: 2.07B
• Enterprise Value: 2.61B
• 1-Year Change: 49.08%
• Ranking: #1870
• Category: Mid-Cap
• Stock Price: $9.91

Market Cap Chart

Since December 1, 1998, BioCryst Pharmaceuticals's market cap has increased from $100.40M to $2.07B, an increase of 1,965.41%. That is a compound annual growth rate of 12.07%.

Market Cap History

Date	Market Cap	% Change
Jun 20, 2025	2.11B	35.68%
Dec 31, 2024	1.56B	26.96%
Dec 29, 2023	1.23B	-42.68%
Dec 30, 2022	2.14B	-14.12%
Dec 31, 2021	2.49B	89.46%
Dec 31, 2020	1.32B	245.25%
Dec 31, 2019	381.00M	-56.94%
Dec 31, 2018	884.80M	83.11%
Dec 29, 2017	483.20M	3.49%
Dec 30, 2016	466.90M	-38.31%
Dec 31, 2015	756.80M	-13.40%
Dec 31, 2014	873.90M	94.59%
Dec 31, 2013	449.10M	522.02%
Dec 31, 2012	72.20M	-35.36%
Dec 30, 2011	111.70M	-51.92%
Dec 31, 2010	232.30M	-7.38%
Dec 31, 2009	250.80M	378.63%
Dec 31, 2008	52.40M	-77.65%
Dec 31, 2007	234.50M	-30.60%
Dec 29, 2006	337.90M	-23.72%
Dec 30, 2005	443.00M	252.71%
Dec 31, 2004	125.60M	3.37%
Dec 31, 2003	121.50M	614.71%
Dec 31, 2002	17.00M	-75.61%
Dec 31, 2001	69.70M	-40.02%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	684.73B
Johnson & Johnson	360.41B
AbbVie	327.31B
Novo Nordisk	326.28B
UnitedHealth Group	273.97B
Abbott Laboratories	231.38B
Novartis AG	227.54B
AstraZeneca	217.06B